These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Pontecorvo MJ, Devous MD, Navitsky M, Lu M, Salloway S, Schaerf FW, Jennings D, Arora AK, McGeehan A, Lim NC, Xiong H, Joshi AD, Siderowf A, Mintun MA, 18F-AV-1451-A05 investigators. Brain; 2017 Mar 01; 140(3):748-763. PubMed ID: 28077397 [Abstract] [Full Text] [Related]
16. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18. Devous MD, Joshi AD, Navitsky M, Southekal S, Pontecorvo MJ, Shen H, Lu M, Shankle WR, Seibyl JP, Marek K, Mintun MA. J Nucl Med; 2018 Jun 01; 59(6):937-943. PubMed ID: 29284675 [Abstract] [Full Text] [Related]
17. Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum. Timmers T, Ossenkoppele R, Wolters EE, Verfaillie SCJ, Visser D, Golla SSV, Barkhof F, Scheltens P, Boellaard R, van der Flier WM, van Berckel BNM. Alzheimers Res Ther; 2019 Jul 04; 11(1):60. PubMed ID: 31272512 [Abstract] [Full Text] [Related]